Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-022461
Filing Date
2016-08-04
Accepted
2016-08-03 20:20:03
Documents
69
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prtk-10q_20160630.htm 10-Q 1355493
2 EX-31.1 prtk-ex311_6.htm EX-31.1 18164
3 EX-31.2 prtk-ex312_7.htm EX-31.2 18328
4 EX-32.1 prtk-ex321_9.htm EX-32.1 6740
5 EX-32.2 prtk-ex322_8.htm EX-32.2 6867
  Complete submission text file 0001564590-16-022461.txt   5728588

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prtk-20160630.xml EX-101.INS 1137479
7 XBRL TAXONOMY EXTENSION SCHEMA prtk-20160630.xsd EX-101.SCH 56490
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20160630_cal.xml EX-101.CAL 45618
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20160630_def.xml EX-101.DEF 188257
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20160630_lab.xml EX-101.LAB 412883
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20160630_pre.xml EX-101.PRE 309078
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 161805415
SIC: 2834 Pharmaceutical Preparations